Author | Enrico Tiacci, MD | OncLive

Author | Enrico Tiacci, MD


Dr. Tiacci on Vemurafenib and Rituximab Combo in Hairy Cell Leukemia

November 28, 2019


Enrico Tiacci, MD, discusses updated data of a phase II trial investigating the combination of vemurafenib and rituximab for patients with relapsed/refractory hairy cell leukemia.

Dr. Tiacci on Standard of Care in Hairy Cell Leukemia Treatment

October 25, 2019


Enrico Tiacci, MD, discusses the current treatment options for patients with hairy cell leukemia. Currently, the standard of care for these patients are purine nucleoside analogs, including pentostatin and cladribine.

Dr. Tiacci on Vemurafenib/Rituximab Combo in HCL

July 02, 2019


Enrico Tiacci, MD, discusses safety and efficacy results of a trial evaluating the BRAF inhibitor vemurafenib combined with rituximab in hairy cell leukemia.